Cargando…

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?

Detalles Bibliográficos
Autor principal: Seghatchian, Jerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425702/
https://www.ncbi.nlm.nih.gov/pubmed/36068156
http://dx.doi.org/10.1016/j.transci.2022.103568
_version_ 1784778507250827264
author Seghatchian, Jerard
author_facet Seghatchian, Jerard
author_sort Seghatchian, Jerard
collection PubMed
description
format Online
Article
Text
id pubmed-9425702
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94257022022-08-30 Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection? Seghatchian, Jerard Transfus Apher Sci Editorial Published by Elsevier Ltd. 2022-10 2022-08-30 /pmc/articles/PMC9425702/ /pubmed/36068156 http://dx.doi.org/10.1016/j.transci.2022.103568 Text en © 2022 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Seghatchian, Jerard
Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title_full Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title_fullStr Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title_full_unstemmed Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title_short Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
title_sort do highly transmissible omicron subtypes ba.4/ba.5 have any impact on the hla class i /ii antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425702/
https://www.ncbi.nlm.nih.gov/pubmed/36068156
http://dx.doi.org/10.1016/j.transci.2022.103568
work_keys_str_mv AT seghatchianjerard dohighlytransmissibleomicronsubtypesba4ba5haveanyimpactonthehlaclassiiiantibodiesofapheresisdonorsandcouldmucosalomicronspecificvaccinespreventtransmissibilityandprovidemoredurableprotection